Glutamine switches vascular smooth muscle cells to synthetic phenotype through inhibiting miR-143 expression and upregulating THY1 expression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glutamine switches vascular smooth muscle cells to synthetic phenotype through inhibiting miR-143 expression and upregulating THY1 expression
Authors
Keywords
Glutamine, Vascular smooth muscle cells, Phenotypic switch, Synthetic phenotype, miR-143, THY1
Journal
LIFE SCIENCES
Volume 277, Issue -, Pages 119365
Publisher
Elsevier BV
Online
2021-03-18
DOI
10.1016/j.lfs.2021.119365
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aortic heterogeneity across segments and under high fat/salt/glucose conditions at the single-cell level
- (2020) Dongxu He et al. National Science Review
- Biomechanical signal communication in vascular smooth muscle cells
- (2020) Jingbo Chen et al. Journal of Cell Communication and Signaling
- Deprivation of glutamine in cell culture reveals its potential for treating cancer
- (2019) Harry Rubin PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Platelet-derived miR-223 promotes a phenotypic switch in arterial injury repair
- (2019) Zhi Zeng et al. JOURNAL OF CLINICAL INVESTIGATION
- TEA Domain Transcription Factor 1 (TEAD1) Promotes Smooth Muscle Cell Proliferation through Up-Regulating SLC1A5-Mediated Glutamine Uptake
- (2019) Islam Osman et al. CIRCULATION RESEARCH
- Role of Vascular Smooth Muscle Cell Phenotypic Switching and Calcification in Aortic Aneurysm Formation
- (2019) Ploingarm Petsophonsakul et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Emerging regulators of vascular smooth muscle cell migration
- (2019) TecLino Afewerki et al. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY
- CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule
- (2019) Chloé Sauzay et al. Frontiers in Cell and Developmental Biology
- Editorial: Thy1/CD90 Surface Glycoprotein: Sensor of Microenvironment?
- (2019) Emanuela Felley-Bosco et al. Frontiers in Cell and Developmental Biology
- Arsenic trioxide induces growth inhibition and death in human pulmonary artery smooth muscle cells accompanied by mitochondrial O2•− increase and GSH depletion
- (2018) Woo Hyun Park et al. ENVIRONMENTAL TOXICOLOGY
- Glutamine Transport and Mitochondrial Metabolism in Cancer Cell Growth
- (2017) Mariafrancesca Scalise et al. Frontiers in Oncology
- Vascular Smooth Muscle Cells in Atherosclerosis
- (2016) Martin R. Bennett et al. CIRCULATION RESEARCH
- Mitochondrial function and glucose metabolism in the placenta with gestational diabetes mellitus: role of miR-143
- (2016) S. Muralimanoharan et al. CLINICAL SCIENCE
- l-Glutamine enhances enterocyte growth via activation of the mTOR signaling pathway independently of AMPK
- (2014) Dan Yi et al. AMINO ACIDS
- MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis (Review)
- (2014) XIN YU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- L-glutamine provides acid resistance for Escherichia coli through enzymatic release of ammonia
- (2013) Peilong Lu et al. CELL RESEARCH
- Fulfilling the metabolic requirements for cell proliferation
- (2012) Salvador Moncada et al. BIOCHEMICAL JOURNAL
- Smooth muscle cell phenotypic switching in atherosclerosis
- (2012) D. Gomez et al. CARDIOVASCULAR RESEARCH
- MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene
- (2012) Rong Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in cervical cancer cells
- (2012) SHAORU LI et al. Oncology Letters
- Signaling Mechanisms That Regulate Smooth Muscle Cell Differentiation
- (2011) Christopher P. Mack ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- miR-143 and miR-145
- (2011) Ashraf Yusuf Rangrez et al. Circulation-Cardiovascular Genetics
- MicroRNAs and Their Therapeutic Potential for Human Diseases: MicroRNAs, miR-143 and -145, Function as Anti-oncomirs and the Application of Chemically Modified miR-143 as an Anti-cancer Drug
- (2010) Yukio Kitade et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Molecular Regulation of Contractile Smooth Muscle Cell Phenotype: Implications for Vascular Tissue Engineering
- (2010) Jeffrey A. Beamish et al. TISSUE ENGINEERING PART B-REVIEWS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation
- (2009) Yunhui Cheng et al. CIRCULATION RESEARCH
- CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell cultures
- (2009) Lynn Kisselbach et al. CYTOTECHNOLOGY
- MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury
- (2009) M. Xin et al. GENES & DEVELOPMENT
- Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster
- (2009) Thomas Boettger et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-145 and miR-143 regulate smooth muscle cell fate and plasticity
- (2009) Kimberly R. Cordes et al. NATURE
- Oxidant and Redox Signaling in Vascular Oxygen Sensing: Implications for Systemic and Pulmonary Hypertension
- (2008) Sachin A. Gupte et al. ANTIOXIDANTS & REDOX SIGNALING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation